Cosentyx

Johnson & Johnson keeps the heat on Tremfya's rivals with at-home injector nod
Fierce Pharma
Fri, 03/1/19 - 11:56 am
JNJ
Janssen
Tremfya
psoriasis
Novartis
Cosentyx
Eli Lilly
Taltz
Tremfya Demonstrates Superiority Over Cosentyx in Ph III Data in Moderate to Severe Plaque Psoriasis
CP Wire
Wed, 12/12/18 - 10:50 am
Tremfya
Cosentyx
Jannsen
chronic plaque psoriasis
Tremfya Demonstrates Superiority Over Cosentyx in Ph III Data in Moderate to Severe Plaque Psoriasis
Wed, 12/12/18 - 10:46 am
Tremfya
Cosentyx
Jannsen
chronic plaque psoriasis
Gilead, Galapagos clear another PhII hurdle for filgotinib, but can they hope to catch up with Novartis’ Cosentyx?
Endpoints
Thu, 09/6/18 - 10:15 am
Gilead Sciences
Galapagos
filgotinib
Novartis
Cosentyx
ankylosing spondylitis
Touting PhIII success for arthritis drug Taltz, Eli Lilly chases rival Novartis in heated immunology race
Endpoints
Thu, 06/28/18 - 09:45 am
Eli Lilly
Taltz
Novartis
ankylosing spondylitis
Cosentyx
Novartis pads Cosentyx's psoriatic arthritis lead with joint-damage label update
Fierce Pharma
Thu, 06/21/18 - 11:57 am
Novartis
Cosentyx
psoriatic arthritis
Amid tough competition, Novartis makes case for rheumatology drug Cosentyx
Pharmaforum
Thu, 06/14/18 - 10:35 pm
Novartis
Cosentyx
ankylosing spondylitis
Novartis beefs up its data bank on Cosentyx’s durable effect on quality of life as well as scalp psoriasis
Endpoints
Fri, 02/16/18 - 09:32 pm
Novartis
Cosentyx
psoriasis
Eli Lilly touts PhIII success for Taltz as rival Novartis stays well out front in crowded immunology race
Endpoints
Tue, 02/13/18 - 09:45 am
Eli Lilly
Taltz
Novartis
ankylosing spondylitis
Cosentyx
Novartis (NVS) Q4 Earnings & Sales Top on Cosentyx, Entresto
NASDAQ.com
Wed, 01/24/18 - 08:10 pm
Novartis
earnings
Cosentyx
Entresto
Novartis goes 2-0 against J&J in psoriasis
Biopharma Dive
Wed, 01/17/18 - 11:36 am
Novartis
JNJ
psoriasis
Cosentyx
Stelara
Novartis Starts Trial on Psoriasis Drug Cosentyx Biosoimilar
Yahoo/Zacks.com
Wed, 01/10/18 - 10:18 am
Novartis
psoriasis
Cosentyx
biosimilars
ankylosing spondylitis
Lilly's Taltz takes Cosentyx rivalry into psoriatic arthritis with new FDA nod
Fierce Pharma
Tue, 12/5/17 - 09:30 am
Eli Lilly
Taltz
Novartis
Cosentyx
FDA
psoriatic arthritis
Novartis spotlights its top 4 blockbuster late-stage pipeline projects
Endpoints
Mon, 11/13/17 - 09:35 am
Novartis
RTH258
wet age-related macular degeneration
AMG 334
migraines
Cosentyx
ACZ885
Novartis strengthens autoimmune indications for Cosentyx
PM Live
Fri, 11/10/17 - 10:21 pm
Novartis
Cosentyx
autoimmune disease
psoriatic arthritis
ankylosing spondylitis
In Novartis' newest Cosentyx push, active, real-life patients take center stage
Fierce Pharma
Mon, 10/9/17 - 10:54 am
Novartis
Cosentyx
drug ads
psoriatic arthritis
Novartis touts 5-year Cosentyx data as it works to hold top spot in psoriasis
Fierce Pharma
Wed, 09/13/17 - 09:43 pm
Novartis
Cosentyx
psoriasis
Novartis' Cosentyx racks up more long-term data in psoriatic arthritis and ankylosing spondylitis
Fierce Pharma
Thu, 06/15/17 - 05:36 pm
Novartis
Cosentyx
psoriatic arthritis
ankylosing spondylitis
3 Big Pharma Companies With the Best Pipelines
Motley Fool
Sun, 04/9/17 - 12:24 pm
JNJ
Actelion
Darzalex
Novartis
Cosentyx
Jakavi
Lucentis
Tasigna
Roche
Venclexta
Tecentriq
emicizumab
Novartis’s Cosentyx Managed to Achieve Blockbuster Status in 2016
Market Realist
Wed, 03/29/17 - 09:31 am
Novartis
Cosentyx
psoriasis

Pages